BG63248B1 - Комбиниран фармацевтичен препарат от lнrн - аналози и антиестрогени за лечение на гинекологични смущения - Google Patents

Комбиниран фармацевтичен препарат от lнrн - аналози и антиестрогени за лечение на гинекологични смущения Download PDF

Info

Publication number
BG63248B1
BG63248B1 BG102660A BG10266098A BG63248B1 BG 63248 B1 BG63248 B1 BG 63248B1 BG 102660 A BG102660 A BG 102660A BG 10266098 A BG10266098 A BG 10266098A BG 63248 B1 BG63248 B1 BG 63248B1
Authority
BG
Bulgaria
Prior art keywords
lhrh
antiestrogen
analogue
treatment
administered
Prior art date
Application number
BG102660A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102660A (en
Inventor
Klaus Stoeckemann
Peter Muhn
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of BG102660A publication Critical patent/BG102660A/xx
Publication of BG63248B1 publication Critical patent/BG63248B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BG102660A 1996-01-29 1998-07-29 Комбиниран фармацевтичен препарат от lнrн - аналози и антиестрогени за лечение на гинекологични смущения BG63248B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19604231A DE19604231A1 (de) 1996-01-29 1996-01-29 Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
PCT/EP1997/000395 WO1997027863A1 (de) 1996-01-29 1997-01-29 Pharmazeutisches kombinationspräparat aus lhrh-analoga und antiöstrogenen zur behandlung von gynäcologischen störungen

Publications (2)

Publication Number Publication Date
BG102660A BG102660A (en) 1999-06-30
BG63248B1 true BG63248B1 (bg) 2001-07-31

Family

ID=7784640

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102660A BG63248B1 (bg) 1996-01-29 1998-07-29 Комбиниран фармацевтичен препарат от lнrн - аналози и антиестрогени за лечение на гинекологични смущения

Country Status (20)

Country Link
US (3) US7309691B2 (de)
EP (1) EP0877621A1 (de)
JP (1) JP2000505422A (de)
KR (1) KR19990082080A (de)
CN (1) CN1209750A (de)
BG (1) BG63248B1 (de)
BR (1) BR9707210A (de)
CZ (1) CZ239198A3 (de)
DE (1) DE19604231A1 (de)
EA (1) EA001178B1 (de)
HU (1) HUP9901288A3 (de)
IL (1) IL125557A0 (de)
MX (1) MX9806082A (de)
NO (1) NO983465L (de)
PL (1) PL328066A1 (de)
SK (1) SK98798A3 (de)
TR (1) TR199801452T2 (de)
TW (1) TW577735B (de)
WO (1) WO1997027863A1 (de)
ZA (1) ZA97741B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US6096764A (en) * 1997-08-21 2000-08-01 Eli Lilly And Company Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration
CZ301912B6 (cs) 1998-04-23 2010-07-28 Zentaris Ivf Gmbh Lécivo na lécení neplodnosti nitrodeložní inseminací
HUP0202429A3 (en) * 1999-08-31 2004-04-28 Schering Ag Use of mesoprogestins (progesterone receptor modulators) for the preparation of pharmaceutical compositions for the treatment and prevention of benign hormone dependent gynecological disorders
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
US7005418B1 (en) 1999-09-23 2006-02-28 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
PL201898B1 (pl) * 1999-09-23 2009-05-29 Zentaris Gmbh Zastosowanie antagonisty LH-RH w leczeniu endometriozy
EP1297850B1 (de) * 2000-07-05 2015-08-19 Takeda Pharmaceutical Company Limited Medizinische zusammensetzungen zur behandlung von mit sexualhormonen verbundenen erkrankungen
DE10050831A1 (de) 2000-10-05 2002-05-02 Veyx Pharma Gmbh Verfahren zum Zyklusstart bei weiblichen Zuchttieren
IL145838A (en) * 2000-10-16 2008-11-03 Pfizer Prod Inc Use of an estrogen agonist / antagonist to produce a drug for the treatment of vaginitis
WO2002056903A2 (en) * 2001-01-17 2002-07-25 Praecis Pharmaceuticals Inc. Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
DE60239207D1 (de) * 2001-08-10 2011-03-31 Takeda Pharmaceutical Gnrh-agonistische kombinationsmittel
WO2006098371A1 (ja) * 2005-03-16 2006-09-21 Masao Igarashi 子宮内膜症および子宮腺筋症の治療剤および予防剤
EP2266568A1 (de) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Pharmazeutische Zubereitung enthaltend LHRH-Antagonisten und PDE V Hemmern zur Behandlung von Sexualhormon abhängigen Erkrankungen
EP2266567A1 (de) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Pharmazeutische Zubereitung enthaltend Cetrorelix und PDE V Hemmern zur Behandlung von Sexualhormon abhängige Erkrankungen
KR20130031339A (ko) * 2010-06-16 2013-03-28 앙도르쉐르슈 인코포레이티드 에스트로겐-관련 질병의 치료 또는 예방 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5457116A (en) * 1993-10-15 1995-10-10 Eli Lilly And Company Methods of inhibiting uterine fibrosis
US5451590A (en) * 1993-12-21 1995-09-19 Eli Lilly & Co. Methods of inhibiting sexual precocity
US5451589A (en) * 1993-12-21 1995-09-19 Eli Lilly And Company Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
US5593987A (en) * 1993-12-21 1997-01-14 Eli Lilly And Company Methods of inhibiting breast disorders
US6096764A (en) 1997-08-21 2000-08-01 Eli Lilly And Company Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration

Also Published As

Publication number Publication date
HUP9901288A3 (en) 2000-03-28
US20010041672A1 (en) 2001-11-15
US7309691B2 (en) 2007-12-18
HUP9901288A2 (hu) 1999-08-30
NO983465L (no) 1998-09-18
PL328066A1 (en) 1999-01-04
CN1209750A (zh) 1999-03-03
US20020198155A1 (en) 2002-12-26
TR199801452T2 (xx) 1998-10-21
EP0877621A1 (de) 1998-11-18
MX9806082A (es) 1998-10-31
BG102660A (en) 1999-06-30
WO1997027863A1 (de) 1997-08-07
KR19990082080A (ko) 1999-11-15
IL125557A0 (en) 1999-03-12
JP2000505422A (ja) 2000-05-09
CZ239198A3 (cs) 1998-11-11
SK98798A3 (en) 1999-03-12
NO983465D0 (no) 1998-07-28
TW577735B (en) 2004-03-01
DE19604231A1 (de) 1997-07-31
EA001178B1 (ru) 2000-10-30
ZA97741B (en) 1997-07-30
EA199800666A1 (ru) 1999-02-25
US20020032156A1 (en) 2002-03-14
BR9707210A (pt) 1999-04-06

Similar Documents

Publication Publication Date Title
Shoham et al. Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone
BG63248B1 (bg) Комбиниран фармацевтичен препарат от lнrн - аналози и антиестрогени за лечение на гинекологични смущения
Broekmans GnRH agonists and uterine leiomyomas
HUT74622A (en) Pharmaceutical compositons for treatment of ovarian estrogen dependent conditions
Coccia et al. GnRH antagonists
US20110306547A1 (en) Lhrh - antagonists in the treatment of fertility disorders
EP0994718B1 (de) Gonadotropin releasing hormon antagonist
JP2010539153A (ja) 閉経前の女性におけるエストロゲン依存症状の治療
JP2005501918A (ja) 制御下の過排卵刺激におけるｈＣＧの使用
US7666836B2 (en) Method for the therapeutic management of endometriosis
Friedman Treatment of uterine myomas with GnRH agonists
BG106584A (bg) Метод за терапевтичен контрол на извънматочна пролиферация на ендометриална тъкан, хронична тазова болка и запушване на фoлопиевата тръба
RU2181598C2 (ru) Восстановление тонической секреции эстрогена из яичников для продолжительных схем лечения
JP2005501919A (ja) 制御下の過排卵刺激におけるｈＣＧ及びＬＨの使用
US11446351B2 (en) Composition for treating one or more estrogen related diseases
CA2244675A1 (en) Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders
AU761274B2 (en) Pharmaceutical combination preparation that consists of LHRH-analogues and antiestrogens for treating gynecological disorders
CA2200541C (en) Lhrh-antagonists in the treatment of fertility disorders
Neves-e-Castro et al. Use of luteinizing hormone-releasing hormone analogs in non-neoplastic gynecologic conditions
CA2341974A1 (en) Gonadotropin releasing hormone antagonist
Akagbosu et al. The use of gonadotropin releasing hormone